Ospedale San Donato

Futó vizsgálatok

• Toboroz

  Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting

  NCT07109375· Chiesi Italia· Forrás

• Toboroz

  TRanscatheter Aortic-Valve Implantation Without On-site Cardiac Surgery

  NCT07604402· University Hospital of Ferrara· Forrás

• Még nem toboroz

  XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients

  NCT07381777· 2. fázis· Gruppo Oncologico Italiano di Ricerca Clinica· Forrás

• Fut, nem toboroz

  TRanscatheter Aortic-Valve Implantation With or Without On-site Cardiac Surgery: the TRACS Trial

  NCT05751577· Azienda Usl di Bologna· Forrás

• Toboroz

  Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients

  NCT05817903· 2. fázis· Consorzio Oncotech· Forrás

• Toboroz

  ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing

  NCT06324682· University Hospital of Ferrara· Forrás

• Toboroz

  Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)

  NCT05601700· 3. fázis· Ente Ospedaliero Ospedali Galliera· Forrás

• Toboroz

  Italian Anderson Fabry Disease Cardiovascular Registry

  NCT06806813· IRCCS Azienda Ospedaliero-Universitaria di Bologna· Forrás

• Fut, nem toboroz

  Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

  NCT04988386· 3. fázis· Eidos Therapeutics, a BridgeBio company· Forrás

• Toboroz

  Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease

  NCT04912323· R3 Vascular Inc.· Forrás

• Toboroz

  A randomized, non-comparative, phase II study investigating the best epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) sequence in advanced or metastatic non-small-cell lung cancer (NSCLC) harboring EGFR mutations

  NCT04811001· 2. fázis· Fondazione Ricerca Traslazionale· Forrás

• Fut, nem toboroz

  Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

  NCT02811861· 3. fázis· Eisai Inc.· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Fabry-betegség2 toboroz
• Aortic stenosis1 toboroz
• Gyermekkori daganatok1 toboroz
• Peripheral artery disease1 toboroz
• Petefészekrák1 toboroz
• Pitvarfibrilláció1 toboroz
• Szívelégtelenség1 toboroz
• Ventricular tachycardia1 toboroz
• Vesedaganat1 toboroz

Lezárt vizsgálatok

• Lezárult

  EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs

  NCT06316128· Heart Care Foundation· Forrás

• Leállították

  Blue Light Photobiomodulation Therapy on Neuroischemic Patients

  NCT04831606· Emoled· Forrás

• Lezárult

  A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

  NCT02975934· 3. fázis· pharmaand GmbH· Forrás

• Lezárult

  IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA

  NCT02963649· Medtronic Endovascular· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Myocarditis9 munka · 0 vizsgálat